Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease

INTRODUCTION: Patients with Inflammatory Bowel Disease (IBD) frequently receive immunomodulating treatment, which may render them at increased risk of an attenuated immune response upon vaccination. In this study, we assessed the effects of different types of commonly prescribed immunosuppressive me...

Descripción completa

Detalles Bibliográficos
Autores principales: Otten, Antonius T., Bourgonje, Arno R., Horinga, Petra P., van der Meulen, Hedwig H., Festen, Eleonora A. M., van Dullemen, Hendrik M., Weersma, Rinse K., van Leer-Buter, Coretta C., Dijkstra, Gerard, Visschedijk, Marijn C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294156/
https://www.ncbi.nlm.nih.gov/pubmed/35865529
http://dx.doi.org/10.3389/fimmu.2022.920333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294156/
https://www.ncbi.nlm.nih.gov/pubmed/35865529
http://dx.doi.org/10.3389/fimmu.2022.920333

Ejemplares similares